| Jessica C Willey, OTR/L | |
|
103 Mayfair Park, Alabaster, AL 35114-5457 | |
| (205) 260-2561 | |
| Not Available |
| Full Name | Jessica C Willey |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 103 Mayfair Park, Alabaster, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104467869 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 18368 (California) | Secondary |
| 225X00000X | Occupational Therapist | 2872 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica C Willey, OTR/L 103 Mayfair Park, Alabaster, AL 35114-5457 Ph: () - | Jessica C Willey, OTR/L 103 Mayfair Park, Alabaster, AL 35114-5457 Ph: (205) 260-2561 |
News Archive
Increasing the testosterone levels of female cancer survivors using testosterone cream did not improve their libido more than a placebo, according to a randomized controlled clinical trial in the May 2 Journal of the National Cancer Institute.
Abbot and AstraZeneca have announced that they have entered into an agreement for AstraZeneca to co-promote Abbott's Trilipix (fenofibric acid), a medication for use alone or in combination with a statin to treat certain lipid disorders. Under the terms of the agreement, AstraZeneca will obtain the non-exclusive right to co-promote Trilipix alongside Abbott in the United States, excluding Puerto Rico. Specific financial terms were not disclosed.
Scientists at The New York Stem Cell Foundation Research Institute successfully designed a revolutionary, high-throughput, robotic platform that automates and standardizes the process of transforming patient samples into stem cells.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced that NextGen® Inpatient Clinicals version 2.4 has earned designation as a premarket conditionally CCHIT Certified® 2011 Inpatient EHR.
The U.S. Food and Drug Administration today approved Berinert, the first treatment for acute abdominal attacks and facial swelling associated with a rare and potentially life-threatening genetic disease called hereditary angioedema (HAE).
› Verified 4 days ago
Charlene H. Mcneill, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N, Suite 220, Alabaster, AL 35007 Phone: 205-621-3778 Fax: 205-621-4835 | |
Vanessa Malcolm, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Red Oak Ln, Alabaster, AL 35007 Phone: 205-616-0832 |